Ramón Clèries

Biographic Data

ID7764645
NAMERamón Clèries
GIVEN NAMESRamón
FAMILY NAMEClèries
SIGNATURECLÈRIES R
AFFILIATIONSInstitut d'Investigació Biomédica de Bellvitge
ORCID0000-0002-3637-4747
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2009
LATEST PUBLICATION YEAR2022
H-INDEX0

  • No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy

    Open AccessRamón Clèries, María Buxó et al.ARTICLEInternational Journal of…2022

    Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…

  • Predicting Ovarian-Cancer Burden in Catalonia by 2030

    Open AccessPaula Peremiquel‐Trillas, Paula Peremiquel-Trillas et al.ARTICLEInternational Journal of…2022

    Ovarian cancer is the most lethal gynaecological cancer in very-high-human-development-index regions. Ovarian cancer incidence and mortality rates are estimated to globally rise by 2035, although incidence and mortality rates depend on the region and prevalence of the associated risk factors. The aim of this study is to assess changes in incidence and mortality of ovarian cancer in Catalonia by 2030. Bayesian autoregressive age-period-cohort mode…

  • Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

    Open AccessRamón Clèries, Alberto Ameijide et al.ARTICLEInternational Journal of…2022

    Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…

  • Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)

    Open AccessRamón Clèries, Alberto Ameijide et al.ARTICLEGaceta Sanitaria2020

    Analizar la supervivencia poblacional del cáncer de mama (CM) en estadios precoces, estimando la tendencia temporal del exceso de mortalidad (EM) a largo plazo en periodos anuales y quinquenales, y determinando, si es posible, una proporción de pacientes que puedan considerarse curadas. Se incluyó la cohorte de pacientes diagnosticadas de CM en estadios I y II antes de los 60 años de edad en Gerona y Tarragona (N = 2453). Se calcularon la supervi…

  • Regstattools

    Open AccessLaura Esteban, Ramón Clèries et al.ARTICLEBMC Public Health2013

    Unlike other similar applications, REGSTATTOOLS does not require local software installation and it is simple to use, fast and easy to interpret. It is a set of web-based statistical tools intended for automated calculation of population indicators that any professional in health or social sciences may require

  • RiskDiff

    Open AccessJoan Valls, Ramón Clèries et al.ARTICLEBMC Public Health2009

    Combining epidemiological with demographical factors is crucial for analysing incidence or mortality from a disease, especially if the population pyramids show substantial differences. The tool implemented may serve to promote and divulgate the use of this method to give advice for epidemiologic interpretation and decision making in public health